Consensus statement of the Canadian MS clinics network on: The use of disease modifying agents in multiple sclerosis;Indications therapeutiques des agents modificateurs du cours de la maladie dans la sclerose en plaques: Declaration commune des medecins des cliniques de sclerose en plaques du Canada

Canadian Journal of Neurological Sciences

Volumn 26, Issue 4, 1999, Pages 274-275

  Oger, J ^a   Freedman, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; GLATIRAMER; INTERFERON BETA SERINE;

CLINICAL FEATURE; DISEASE COURSE; HUMAN; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELAPSE; SHORT SURVEY; TREATMENT INDICATION;

EID: 0032692226     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100000378     Document Type: Short Survey

References (0)